Study Watch Atrial Fibrillation (AF) Detection Investigation
NCT ID: NCT04074434
Last Updated: 2019-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2018-11-12
2019-07-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atrial Fibrillation Algorithms Clinical Validation Study
NCT04699812
Anatomical Navigation for Guided Electrophysiology in AFL and AFib
NCT07210151
Study Watch AF Detection At Home
NCT04546763
Concomitant LAAC/AF Ablation (Watchman FLX Pro)
NCT07041125
WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation Rhythm
NCT03835338
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All Participants
Study Watch
Study Watch is a miniaturized physiological data monitoring and data collection device for continuous recording of physiological and environmental data
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Study Watch
Study Watch is a miniaturized physiological data monitoring and data collection device for continuous recording of physiological and environmental data
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read and speak English
* Able and willing to sign written Informed Consent
* Interest in participating in the study
* Subjects with a known history of AF (including persistent or paroxysmal AF)
* Without significant limitation in ability to participate in the study, in the opinion of the investigator.
Exclusion Criteria
* Known severe allergy to nickel or metal jewelry
* Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Verily Life Sciences LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Diego Cardiac Center
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
100145
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.